Sexual dimorphism in schizophrenia: is there a need for gender-based protocols?
- 1 July 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 11 (7) , 951-959
Abstract
Gender differences have been reported in various aspects of schizophrenia, including its epidemiology, clinical course and the response to antipsychotic medications. Over the past few years the authors have been investigating sex differences in brain function in individuals with schizophrenia and have found an intriguing disturbance of normal sexual dimorphism during emotional and cognitive processing. These results can be partly accounted for by altered levels of sex steroid hormones (i.e., estrogen and testosterone) in patients. A handful of clinical research groups have tried low doses of estrogen, testosterone or their precursors as adjunct therapies to the currently available antipsychotic medications in women and men with schizophrenia. The results have been promising, but further investigation is warranted. In the future, new more specific steroidal compounds will be developed and we will see more studies examining sex differences in the brain, behavior and mental health problems. This research will help to identify individuals who may benefit greatest from adjunct hormonal therapies and will further our understanding of the etiology of schizophrenia and other psychiatric disorders.Keywords
This publication has 107 references indexed in Scilit:
- Synaptic changes in the brain of subjects with schizophreniaInternational Journal of Developmental Neuroscience, 2011
- Disturbed sexual dimorphism of brain activation during mental rotation in schizophreniaSchizophrenia Research, 2010
- The organizational–activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissuesHormones and Behavior, 2009
- Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trialCritical Care, 2008
- Secondary Effects of Antipsychotics: Women at Greater Risk Than MenSchizophrenia Bulletin, 2008
- An increased risk of stroke among young schizophrenia patientsSchizophrenia Research, 2008
- Diagnostic and Sex Effects on Limbic Volumes in Early-Onset Bipolar Disorder and SchizophreniaSchizophrenia Bulletin, 2007
- A Systematic Review of Mortality in SchizophreniaArchives of General Psychiatry, 2007
- Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trialPsychoneuroendocrinology, 2007
- Estrogenic Agonist Activity of ICI 182,780 (Faslodex) in Hippocampal Neurons: Implications for Basic Science Understanding of Estrogen Signaling and Development of Estrogen Modulators with a Dual Therapeutic ProfileThe Journal of Pharmacology and Experimental Therapeutics, 2006